269 results on '"Gulei, Diana"'
Search Results
2. Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy?
3. Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
4. Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma
5. In vivo imaging system (IVIS) therapeutic assessment of tyrosine kinase inhibitor-loaded gold nanocarriers for acute myeloid leukemia: a pilot study
6. RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high‐grade myelodysplastic syndromes.
7. Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models
8. miRNA Expression Assays
9. Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
10. Nanoscale delivery systems for microRNAs in cancer therapy
11. The impact of climate change and land use on the cancer burden in the 21st century
12. List of contributors
13. Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibition
14. Phytol: A review of biomedical activities
15. Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
16. Restoring the p53 ‘Guardian’ Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9
17. Therapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum
18. Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevance
19. RNA sequencing suggests that non‐coding RNAs play a role in the development of acquired haemophilia
20. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator
21. Pitfalls in patenting academic CAR-T cells therapy
22. miRNA Expression Assays
23. Overview upon miR-21 in lung cancer: focus on NSCLC
24. Current trends in luminescence-based assessment of apoptosis
25. Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML
26. Characterization of extrachromosomal circular DNA in patients with acute myeloid leukemia: proof-of-concept report using cohorts from Beijing and Shanghai
27. Noncoding RNAs in Lung Cancer Angiogenesis
28. Insights into the Human Microbiome and Its Connections with Prostate Cancer.
29. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression
30. New Insights into the Multivariate Analysis of SER Spectra Collected on Blood Samples for Prostate Cancer Detection: Towards a Better Understanding of the Role Played by Different Biomolecules on Cancer Screening: A Preliminary Study
31. Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies
32. SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer
33. Chapter 4 - The impact of climate change and land use on the cancer burden in the 21st century
34. Cancer Mechanisms and Emerging Therapies
35. Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
36. Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene
37. The Possible Non-Mutational Causes of FVIII Deficiency: Non-Coding RNAs and Acquired Hemophilia A
38. Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review)
39. Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
40. Cardiomyopathies and Arrhythmias Induced by Cancer Therapies
41. Activation of Necroptosis by Engineered Self Tumor-Derived Exosomes Loaded with CRISPR/Cas9
42. Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy
43. Development of a Curcumin-Loaded Polymeric Microparticulate Oral Drug Delivery System for Colon Targeting by Quality-by-Design Approach
44. The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-Analysis
45. PSA Based Biomarkers, Imagistic Techniques and Combined Tests for a Better Diagnostic of Localized Prostate Cancer
46. Spontaneous and Induced Animal Models for Cancer Research
47. The Malignant Role of Exosomes as Nanocarriers of Rare RNA Species
48. Macrophages Interaction and MicroRNA Interplay in the Modulation of Cancer Development and Metastasis
49. Adipocyte-Based Cell Therapy in Oncology: The Role of Cancer-Associated Adipocytes and Their Reinterpretation as Delivery Platforms
50. miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.